RNA - Avidity Biosciences  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RNA is currently covered by 11 analysts with an average price target of $55.78. This is a potential upside of $20.34 (438.42%) from yesterday's end of day stock price of $10.36.

Avidity Biosciences 's activity chart (see below) currently has 91 price targets and 100 ratings on display. The stock rating distribution of RNA is 86.67% BUY and 13.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 86.97% with an average time for these price targets to be met of 374.21 days.

Highest price target for RNA is $74, Lowest price target is $25, average price target is $55.78.

Most recent stock forecast was given by from CANTOR FITZGERALD on 18-Jun-2026. First documented stock forecast 07-Jul-2020.

Best performing analysts who are covering RNA - Avidity Biosciences :

Andrew Fein Ananda Ghosh Yanan Zhu Steven Seedhouse Luca Issi

Currently out of the existing stock ratings of RNA, 13 are a BUY (86.67%), 2 are a HOLD (13.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Jun-2024

$25

$11.81 (89.54%)

$65

2 months 26 days ago
(18-Jun-2026)

4/5 (80%)

$12.34 (97.47%)

510

Buy Since 07-Jul-2020

$25

$11.81 (89.54%)

$72

3 months 29 days ago
(15-May-2026)

4/5 (80%)

$11.77 (88.96%)

949

Hold Since 01-May-2026

$87

4 months 12 days ago
(01-May-2026)

3/4 (75%)

$46.78 (116.31%)

194

Buy Since 04-Jan-2023

$25

$11.81 (89.54%)

6 months 2 days ago
(11-Mar-2026)

3/4 (75%)

$10.2 (68.92%)

561

Buy Since 18-Dec-2025

$72

$58.81 (445.87%)

8 months 26 days ago
(18-Dec-2025)

1/1 (100%)

$-0.14 (-0.19%)

71

Show more analysts

Please expand the browser size to see the chart

What is RNA (Avidity Biosciences ) average time for price targets to be met?

On average it took 374 days for the stock forecasts to be reached, with an average price target met ratio of 86.97%.

Which analyst most recently updated their price target on RNA (Avidity Biosciences )?

Joshua Schimmer

Which analyst has the most public recommendations on RNA (Avidity Biosciences )?

Joshua Schimmer has 2 price targets and 1 ratings on RNA

Which analyst is the currently most bullish on RNA (Avidity Biosciences )?

Eric Schmidt with the highest potential upside of $85.64

Which analyst is the currently most reserved on RNA (Avidity Biosciences )?

Steven Seedhouse with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?